Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biomatrix (BXM) Looking Great -- Ignore unavailable to you. Want to Upgrade?

To: Mike Relyea who wrote (409)	2/27/1998 6:37:00 PM
From: John McCarthy	Read Replies (2) \| Respond to of 569

Mike - First, so that you know, I am long BIOX and plan to buy ANIK as BIOX rises (I hope). Your comments about ANIK are dead on. Please allow me to add, ANIK is also "ON TOP OF" an anti-adhesion product which is well into Phase I and they have about a years lead on BIOX. (minimum) The anti-adhesion market is $1.2 billion, growing, and NOBODY has a handle on it. If HA works for this indication, ANIK is going to have to buy a lot of bricks and cement to build the facilities for its O/A and Anti-Adhesion offerings. (Note:Please check out a prior post of mine here, about 50 back that does a snapshot of all the players in this market.) For reasons not clear to me, AND I DON'T CARE <g> Eduardo wants to kill me everytime I say that it will take 1 year before OrthoVisc can sell in the USA. For starters I am a lay person, not a doctor. Eduardo is a doctor. And I imagine, based on his writings, a good one. Now, notwithstanding that particuliar shortcoming of mine <g> ANIK still has to do (a) an Advisory Meeting (my guess is July) and (b) a final (FDA) meeting (my guess is December). Am I absolutely sure of this? NO! It is simply my best guess. And I have been thru several wicked FDA meetings (DEPO and NPRO) and some good ones so I feel like a beat up veteran with respect to them. (They just killed a BTGC product because they want more tests) Do I see any chance of ANIK failing either of these meetings? I think they have a 99.99% lock on it. Frankly, what is the big deal about the wait? You want to hang onto this stuff for 18 months anyway. So I don't get it when people bristle. That's it. I've tried to answer your question, and hope you will answer a few for me. What is TMJ? How big is the market (can you post a link)? Have they filed with the FDA already on this? Lastly, whats your 2 cents on why BIOX has not moved? Do you have any insight as to how well SYNVISC is doing out there in the real world? Regards, John